Back to search

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Genomic landscape of entrectinib resistance from ctDNA analysis in STARTRK-2DOI 10.1093/annonc/mdz394.017
Drug resistance: origins, evolution and characterization of genomic clones and the tumor ecosystem to optimize precise individualized therapySemantic proximity
OA 09.01 Characterizing the Genomic Landscape of EGFR C797S in Lung Cancer Using ctDNA Next-Generation SequencingSemantic proximity
Deep ctDNA Profiling Demonstrates Genomic Features of Metastatic Disease.Semantic proximity
Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapySemantic proximity
Genome-based cancer therapeutics: targets, kinase drug resistance and future strategies for precision oncologySemantic proximity
Single-cell RNA sequencing and bioinformatics as tools to decipher cancer heterogenicity and mechanisms of drug resistanceSemantic proximity
Comprehensive genomic profiling of over 10,000 advanced solid tumors.Semantic proximity
Pre‐ and post‐treatment blood‐based genomic landscape of patients with ROS1 or NTRK fusion‐positive solid tumours treated with entrectinibSemantic proximity
CRISPR screening and cell line IC50 data reveal novel key genes for trametinib resistanceSemantic proximity
Single-cell DNA sequencing reveals complex mechanisms of resistance to quizartinibSemantic proximity
Finding the mutations that drive resistance.Semantic proximity
EGFR pharmacogenomics: the story continues to mutate and evolve.Semantic proximity
Select a neighboring publication to make it the new centre.